18 November 2025 Man Wah reported its Sep-ended 1HFY26 results with top line declined by 3.1% YoY to HK$8.04bn mainly due to a MSD YoY drop in both sofas and bedding sales. GPM increased by 0.9ppt YoY to 40.4%. The
17 November 2025 During the review period, Precision Tsugami (China) (PTC) recorded a sustained increase in orders from key downstream industries, particularly the automobile parts and components sector. This translated into a robust 1H26, with sales and NP increased by
14 November 2025 JE reports its 1H26 (Yr ended Mar) sales of USD1.8bn, representing a YoY marginal decline of 1.1%. Reported NP increased by 2.8% YoY to USD133.3m in 1H26. Stripping off the effect of forex effect and restructuring costs,
13 November 2025 Anta announced its 3Q25 operational results, with retail sales for its Anta Core Brand recorded a LSD growth YoY (2Q25: +LSD, 1Q25: +HSD). Adult sales grew by LSD YoY and kids sales grew by MSD YoY. Online
3 November 2025 Sany Heavy announced its 3Q25 business update with revenue increased 14.1% YoY to Rmb18.1bn in 9M25. Net profit grew by 22.9% YoY to Rmb1.7bn in 9M25. Through comprehensive initiatives to enhance operational quality and efficiency, combined with
23 Oct 2025 Xtep announced its 3Q25 operational results, with retail sales for its Xtep Core Brand recorded a LSD growth YoY, as compared with LSD/MSD growth in 2Q25/1Q25. Breaking down by month, sales in Jul/Aug were better than Sep,
20 Oct 2025 Precision Tsugami (China) (PTC) issued a positive profit alert, citing that benefitted from the sustained recover of domestic economy, the company’s 1H26 (Year ended Mar) NP is expected to amount to Rmb502m, representing a YoY increase of
15 Oct 2025 361 Degrees announced its 3Q25 operational results, with offline retail sales for its 361° Core Brand recorded a ~10% growth YoY (2Q25: ~10%, 1Q25: +10%-15%), while 361° Kids was up by ~10% growth YoY (2Q25: ~10%, 1Q25:
10 Oct 2025 Gold extended its historic rally to break above $4,000 an ounce for the first time on Wednesday, driven by strong investment demand amid broader geopolitical and economic uncertainty, along with expectations of further interest rate cuts from
10 Oct 2025 On Monday, Mirxes announced a strategic joint venture (JV) with Xeraya Opportunities Fund PCC to establish MYRNA Diagnostics. Under the terms of agreement, Mirxes and Xeraya will contribute US$2 million and US$3 million, respectively, aligned with their
